Literature DB >> 30024886

Correction of copy number induced false positives in CRISPR screens.

Antoine de Weck1, Javad Golji2, Michael D Jones2, Joshua M Korn2, Eric Billy1, E Robert McDonald2, Tobias Schmelzle1, Hans Bitter2, Audrey Kauffmann1.   

Abstract

Cell autonomous cancer dependencies are now routinely identified using CRISPR loss-of-function viability screens. However, a bias exists that makes it difficult to assess the true essentiality of genes located in amplicons, since the entire amplified region can exhibit lethal scores. These false-positive hits can either be discarded from further analysis, which in cancer models can represent a significant number of hits, or methods can be developed to rescue the true-positives within amplified regions. We propose two methods to rescue true positive hits in amplified regions by correcting for this copy number artefact. The Local Drop Out (LDO) method uses the relative lethality scores within genomic regions to assess true essentiality and does not require additional orthogonal data (e.g. copy number value). LDO is meant to be used in screens covering a dense region of the genome (e.g. a whole chromosome or the whole genome). The General Additive Model (GAM) method models the screening data as a function of the known copy number values and removes the systematic effect from the measured lethality. GAM does not require the same density as LDO, but does require prior knowledge of the copy number values. Both methods have been developed with single sample experiments in mind so that the correction can be applied even in smaller screens. Here we demonstrate the efficacy of both methods at removing the copy number effect and rescuing hits from some of the amplified regions. We estimate a 70-80% decrease of false positive hits with either method in regions of high copy number compared to no correction.

Entities:  

Mesh:

Year:  2018        PMID: 30024886      PMCID: PMC6067744          DOI: 10.1371/journal.pcbi.1006279

Source DB:  PubMed          Journal:  PLoS Comput Biol        ISSN: 1553-734X            Impact factor:   4.475


  20 in total

1.  Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.

Authors:  E Robert McDonald; Antoine de Weck; Michael R Schlabach; Eric Billy; Konstantinos J Mavrakis; Gregory R Hoffman; Dhiren Belur; Deborah Castelletti; Elizabeth Frias; Kalyani Gampa; Javad Golji; Iris Kao; Li Li; Philippe Megel; Thomas A Perkins; Nadire Ramadan; David A Ruddy; Serena J Silver; Sosathya Sovath; Mark Stump; Odile Weber; Roland Widmer; Jianjun Yu; Kristine Yu; Yingzi Yue; Dorothee Abramowski; Elizabeth Ackley; Rosemary Barrett; Joel Berger; Julie L Bernard; Rebecca Billig; Saskia M Brachmann; Frank Buxton; Roger Caothien; Justina X Caushi; Franklin S Chung; Marta Cortés-Cros; Rosalie S deBeaumont; Clara Delaunay; Aurore Desplat; William Duong; Donald A Dwoske; Richard S Eldridge; Ali Farsidjani; Fei Feng; JiaJia Feng; Daisy Flemming; William Forrester; Giorgio G Galli; Zhenhai Gao; François Gauter; Veronica Gibaja; Kristy Haas; Marc Hattenberger; Tami Hood; Kristen E Hurov; Zainab Jagani; Mathias Jenal; Jennifer A Johnson; Michael D Jones; Avnish Kapoor; Joshua Korn; Jilin Liu; Qiumei Liu; Shumei Liu; Yue Liu; Alice T Loo; Kaitlin J Macchi; Typhaine Martin; Gregory McAllister; Amandine Meyer; Sandra Mollé; Raymond A Pagliarini; Tanushree Phadke; Brian Repko; Tanja Schouwey; Frances Shanahan; Qiong Shen; Christelle Stamm; Christine Stephan; Volker M Stucke; Ralph Tiedt; Malini Varadarajan; Kavitha Venkatesan; Alberto C Vitari; Marco Wallroth; Jan Weiler; Jing Zhang; Craig Mickanin; Vic E Myer; Jeffery A Porter; Albert Lai; Hans Bitter; Emma Lees; Nicholas Keen; Audrey Kauffmann; Frank Stegmeier; Francesco Hofmann; Tobias Schmelzle; William R Sellers
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

2.  Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.

Authors:  Tim Wang; Haiyan Yu; Nicholas W Hughes; Bingxu Liu; Arek Kendirli; Klara Klein; Walter W Chen; Eric S Lander; David M Sabatini
Journal:  Cell       Date:  2017-02-02       Impact factor: 41.582

3.  Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival.

Authors:  Bart Lutterbach; Qinwen Zeng; Lenora J Davis; Harold Hatch; Gaozhen Hang; Nancy E Kohl; Jackson B Gibbs; Bo-Sheng Pan
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

4.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Authors:  Lars Zender; Mona S Spector; Wen Xue; Peer Flemming; Carlos Cordon-Cardo; John Silke; Sheung-Tat Fan; John M Luk; Michael Wigler; Gregory J Hannon; David Mu; Robert Lucito; Scott Powers; Scott W Lowe
Journal:  Cell       Date:  2006-06-30       Impact factor: 41.582

5.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.

Authors:  Craig H Mermel; Steven E Schumacher; Barbara Hill; Matthew L Meyerson; Rameen Beroukhim; Gad Getz
Journal:  Genome Biol       Date:  2011-04-28       Impact factor: 13.583

6.  BAGEL: a computational framework for identifying essential genes from pooled library screens.

Authors:  Traver Hart; Jason Moffat
Journal:  BMC Bioinformatics       Date:  2016-04-16       Impact factor: 3.169

7.  Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression.

Authors:  Joseph Rosenbluh; Han Xu; William Harrington; Stanley Gill; Xiaoxing Wang; Francisca Vazquez; David E Root; Aviad Tsherniak; William C Hahn
Journal:  Nat Commun       Date:  2017-05-23       Impact factor: 14.919

8.  Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.

Authors:  Robin M Meyers; Jordan G Bryan; James M McFarland; Barbara A Weir; Ann E Sizemore; Han Xu; Neekesh V Dharia; Phillip G Montgomery; Glenn S Cowley; Sasha Pantel; Amy Goodale; Yenarae Lee; Levi D Ali; Guozhi Jiang; Rakela Lubonja; William F Harrington; Matthew Strickland; Ting Wu; Derek C Hawes; Victor A Zhivich; Meghan R Wyatt; Zohra Kalani; Jaime J Chang; Michael Okamoto; Kimberly Stegmaier; Todd R Golub; Jesse S Boehm; Francisca Vazquez; David E Root; William C Hahn; Aviad Tsherniak
Journal:  Nat Genet       Date:  2017-10-30       Impact factor: 38.330

9.  The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity.

Authors:  Chrysiis Michaloglou; Waltraut Lehmann; Typhaine Martin; Clara Delaunay; Andreas Hueber; Louise Barys; Honglin Niu; Eric Billy; Markus Wartmann; Moriko Ito; Christopher J Wilson; Mary Ellen Digan; Andreas Bauer; Hans Voshol; Gerhard Christofori; William R Sellers; Francesco Hofmann; Tobias Schmelzle
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.

Authors:  Michael K Kiessling; Sven Schuierer; Silke Stertz; Martin Beibel; Sebastian Bergling; Judith Knehr; Walter Carbone; Cheryl de Vallière; Joelle Tchinda; Tewis Bouwmeester; Klaus Seuwen; Gerhard Rogler; Guglielmo Roma
Journal:  BMC Genomics       Date:  2016-09-09       Impact factor: 3.969

View more
  5 in total

Review 1.  Using human genetics to improve safety assessment of therapeutics.

Authors:  Keren J Carss; Aimee M Deaton; Alberto Del Rio-Espinola; Dorothée Diogo; Mark Fielden; Diptee A Kulkarni; Jonathan Moggs; Peter Newham; Matthew R Nelson; Frank D Sistare; Lucas D Ward; Jing Yuan
Journal:  Nat Rev Drug Discov       Date:  2022-10-19       Impact factor: 112.288

2.  Combined gene essentiality scoring improves the prediction of cancer dependency maps.

Authors:  Wenyu Wang; Alina Malyutina; Alberto Pessia; Jani Saarela; Caroline A Heckman; Jing Tang
Journal:  EBioMedicine       Date:  2019-11-12       Impact factor: 8.143

3.  CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.

Authors:  Musaddeque Ahmed; Fraser Soares; Ji-Han Xia; Yue Yang; Jing Li; Haiyang Guo; Peiran Su; Yijun Tian; Hyung Joo Lee; Miranda Wang; Nayeema Akhtar; Kathleen E Houlahan; Almudena Bosch; Stanley Zhou; Parisa Mazrooei; Junjie T Hua; Sujun Chen; Jessica Petricca; Yong Zeng; Alastair Davies; Michael Fraser; David A Quigley; Felix Y Feng; Paul C Boutros; Mathieu Lupien; Amina Zoubeidi; Liang Wang; Martin J Walsh; Ting Wang; Shancheng Ren; Gong-Hong Wei; Housheng Hansen He
Journal:  Nat Commun       Date:  2021-03-19       Impact factor: 14.919

4.  Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects.

Authors:  Joshua M Dempster; Isabella Boyle; Francisca Vazquez; David E Root; Jesse S Boehm; William C Hahn; Aviad Tsherniak; James M McFarland
Journal:  Genome Biol       Date:  2021-12-20       Impact factor: 13.583

5.  Complementary CRISPR genome-wide genetic screens in PARP10-knockout and overexpressing cells identify synthetic interactions for PARP10-mediated cellular survival.

Authors:  Jude B Khatib; Emily M Schleicher; Lindsey M Jackson; Ashna Dhoonmoon; George-Lucian Moldovan; Claudia M Nicolae
Journal:  Oncotarget       Date:  2022-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.